墨西哥基于人群的麻疹血清学调查:对麻疹再现的启示
该研究利用2022年ENSANUT调查的概率人群样本,通过斑块减少中和试验(PRNT)和抗麻疹IgG ELISA估算疫苗接种诱导的血清状态。PRNT血清阳性率为82.4%(95%CI 79.6, 85.0%),ELISA为61.1%(95%CI 58.6, 63.7%)。20-29岁组PRNT血清阳性率最低(63.6%)。
要点
- PRNT血清阳性率为82.4%,ELISA为61.1%。
- 20-29岁组PRNT血清阳性率最低,为63.6%。
- 年轻成人低血清阳性率可能提示第二剂次覆盖不足和/或免疫力减弱。
核心结论
- 年轻成人血清阳性率低,提示1989-2008年出生队列可能第二剂次覆盖不足和/或在无病毒循环情况下免疫力减弱。
- 若输入麻疹病例,年轻成人和成人的易感性可能促进疫情暴发。
研究设计与样本
- 使用2022年ENSANUT调查的概率人群样本,通过PRNT和抗麻疹IgG ELISA估算疫苗接种诱导的血清状态。
主要发现
- PRNT血清阳性率为82.4%(95%CI 79.6, 85.0%)。
- ELISA血清阳性率为61.1%(95%CI 58.6, 63.7%)。
- 20-29岁年龄组PRNT血清阳性率最低(63.6%),其次为30-39岁组(71.8%)和40-49岁组(77.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measles is a highly contagious, potentially life-threatening viral disease targeted for global elimination. Deficiencies in vaccination programs and vaccine-induced immunity waning may favor re-emergence. In 2020, Mexico experienced an outbreak, mainly affecting adults in urban areas. METHODS: To estimate vaccination-induced serostatus, we used a probabilistic population-based sample of individuals from the ENSANUT survey in 2022. Seroprevalence was estimated by plaque reduction neutralization test (PRNT) and anti-measles IgG ELISA. RESULTS: Seroprevalence was 82.4 % (95 %CI 79.6, 85.0 %) by PRNT and 61.1 % (95 %CI 58.6, 63.7 %) by ELISA. The 20-29 years of age group showed the lowest PRNT seroprevalence (63.6 %), followed by the 30-39 group (71.8 %) and 40-49 (77.7 %). DISCUSSION: Low seroprevalence in young adults suggests possible low coverage of the second dose and/or waning immunity in absence of viral circulation in the 1989-2008 birth cohorts. In case of imported introduction of measles cases, susceptibility in young adults and adults could facilitate an outbreak.
引用
- Carnalla M, Gaspar-Castillo C, Dimas-González J, et al. A population-based measles serosurvey in Mexico: Implications for re-emergence. Vaccine. 2025. PMID: 39970596. doi:10.1016/j.vaccine.2025.126886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。